Are peptide drugs FDA approved today?
Yes: FDA-approved peptide drugs exist. That does not mean every peptide product is a medicine, or that a catalog, research-use, compounded, or chemically similar product has the same approval status.
Why does category context matter?
Public awareness is often narrower than the category itself. Product-specific examples include approved insulin products for diabetes, GLP-1 receptor agonists for defined indications, and ziconotide, a 25-amino-acid peptide used as PRIALT for severe chronic pain when intrathecal therapy is warranted.
The useful takeaway is not that peptide signaling validates every peptide product. It is that approved peptide drugs exist across different clinical contexts, each tied to its own indication, evidence, quality system, and label.
It keeps the reader from mistaking visibility for novelty.
How does this frame newer GLP compounds?
It places newer GLP-class compounds inside an established drug-development lineage while preserving the boundary: approval belongs to a reviewed product for a defined use, not to a molecule category by association.